GV is Alphabet-backed but operates as an autonomous, returns-first multi-stage venture firm investing across technology and life sciences. It is especially active in AI-native, technically differentiated companies and combines long-duration capital with hands-on operating support, while maintaining strict discipline on valuation and price-to-value fit.
Evaluation weights
How much weight this investor places on each dimension. Totals 100%.
Revenue, growth, and unit economics
Size, timing, and competitive landscape
Founder experience and execution ability
Differentiation and technical quality
- Biased toward technically deep founders over purely commercial teams
- Willing to invest early in frontier technology if the moat is real
- More flexible on round leadership than many firms
- Aggressive on category-defining opportunities but conservative on price
Pitch difficulty
How hard it is to get a meeting and close funding from this investor.
Deals closed in a typical year.
Rounds led in the last 12 months.
Decks reviewed in a typical year.
Share of pitches that get funded.
Estimated — public data is not fully disclosed.
- Top-tier brand attracts highly competitive deal flow
- High bar for technical moat and founder quality
- Invests across many sectors but only in companies with outsized market potential
- Strict valuation discipline eliminates many otherwise attractive deals
GV sees high deal volume globally, invests over $1 billion annually, and has flexibility across stages and sectors, but it sets a high bar on founder quality, technical differentiation, market scale, and valuation discipline. The combination of brand access, multi-stage capital, and a returns-first mandate means it can choose from the best opportunities and walk away from overpriced deals.
Green flags
What drives a yes for this investor.
- Exceptional founders with strong technical depth and ambition
- Clear technical moat or step-change product advantage
- Large, durable market with strong timing tailwinds
- Attractive value-to-price ratio relative to stage and company quality
- Potential for a long-term multi-stage relationship
Red flags
What kills deals and gets a fast no.
- Pricing the round too aggressively relative to traction or stage
- Presenting an AI story without real technical differentiation
- Targeting a market that is too small or too short-lived for venture-scale returns
- Lack of conviction in the founding team or weak founder-market fit
- Later-stage metrics that do not support scalability, retention, or category leadership
How to win
Patterns that lead to successful pitches.
- Lead with the founder's unique technical insight and why this team is uniquely suited to win
- Show a non-obvious technical moat, not just strong positioning or branding
- Frame the company as attacking a very large market with durable tailwinds, especially around AI or infrastructure shifts
- Be explicit about why the current round price offers compelling upside relative to stage and traction
- Demonstrate openness to a long-term, multi-stage partnership and use of GV's operating platform
Fund strategy & identity
Who they are and how they operate.
- Invests across Seed, Series A, Series B, Series C, and Growth with flexible ownership targets
- Backs companies across enterprise, consumer, frontier tech, fintech, and life sciences
- Uses long-term, single-LP capital to support companies across multiple rounds
- Applies hard valuation discipline, passing when price does not match stage, quality, or upside
- Pairs capital with platform resources in design, engineering, marketing, and talent
Investment focus
Industries, themes, and typical ARR expectations.
Investment thesis
Core beliefs and strategy behind their investing approach.
Decision patterns
How they evaluate and make investment decisions.
Notable investments
Key portfolio companies and why they fit the thesis.
Key people
Partners who lead investments and shape the thesis.
Public voice
Notable statements and public positions.
Similar investors
Firms with overlapping stage and industry focus.
